Clinical effectiveness of pharmacist administration of long-acting injectable buprenorphine: Findings from the EPIC-MATOD study
Drug Alcohol Rev
.
2024 May 3.
doi: 10.1111/dar.13856.
Online ahead of print.
Authors
Elizabeth Grist
1
,
Ali Cheetham
1
,
John Jackson
2
,
Pene Wood
3
4
5
,
Sarah Lord
6
,
Angelo Pricolo
7
,
Ferghal Armstrong
8
,
Kirsty Morgan
1
9
,
Catherine Nguyen
10
,
Tom Tran
11
,
Suzanne Nielsen
1
Affiliations
1
Monash Addiction Research Centre, Eastern Health Clinical School, Monash University Peninsula Campus, Melbourne, Australia.
2
Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.
3
College of Science, Health and Engineering, La Trobe University, Bendigo, Australia.
4
Wathaurong Aboriginal Health Service, Melbourne, Australia.
5
IPC Health, Melbourne, Australia.
6
Pharmacotherapy Advocacy Meditation and Support Service, Melbourne, Australia.
7
Orygen Youth Mental Health, Melbourne, Australia.
8
Turning Point Eastern Treatment Services, Melbourne, Australia.
9
Peninsula Health, Frankston, Australia.
10
Footscray Central Pharmacy, Melbourne, Australia.
11
Daffey's Pharmacy, Melbourne, Australia.
PMID:
38699894
DOI:
10.1111/dar.13856
No abstract available
Publication types
Letter
Grants and funding
Alcohol and Drug Research Innovation Agenda (ADRIA) grant
#2025894/National Health and Medicial Research Council